Effect of Vitamin D on Management of Attention Deficit Hyperactivity Disorder
- Conditions
- Attention Deficit Hyperactivity Disorder.Attention-deficit hyperactivity disorders
- Registration Number
- IRCT20161104030698N1
- Lead Sponsor
- Esfahan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 84
1- In the age group of 13-6 years
2- Attention deficit hyperactivity disorder has been diagnosed and taken appropriate medications by the child and adolescent psychiatrist
3- Both groups take the same drugs at the same dose. Due to various psychiatric problems in this disorder and the ethical abnormal use of Ritalin, patients in the two groups take other drugs other than Ritalin according to the needs of the psychiatrist, but the range of medications used in the two groups is the same
4- Resident in Isfahan city
1. Use of any non-pharmaceutical treatment
2. Use of vitamin D and multivitamins supplement, foods rich in vitamin D or any supplementation of vitamin D received three months before the start of the study
3. Patients with other chronic diseases except for ?attention deficit hyperactivity disorder
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 25-hydroxy Vitamin D3. Timepoint: At the beginning of the study and after 12 weeks of the intervention. Method of measurement: Enzyme-linked immunosorbent assay (ELISA) kit.;Serum levels of C-reactive protein. Timepoint: At the beginning of the study and after 12 weeks of the intervention. Method of measurement: Enzyme-linked immunosorbent assay (ELISA) kit.;Serum levels of interleukin-6. Timepoint: At the beginning of the study and after 12 weeks of the intervention. Method of measurement: enzyme-linked immunosorbent assay (ELISA) kit.;Serum levels of homocysteine. Timepoint: At the beginning of the study and after 12 weeks of the intervention. Method of measurement: Enzyme-linked immunosorbent assay (ELISA) kit.;Serum levels of superoxide dismutase. Timepoint: At the beginning of the study and after 12 weeks of the intervention. Method of measurement: Spectrophotometric method.
- Secondary Outcome Measures
Name Time Method Food intake. Timepoint: At the beginning of the study. Method of measurement: Food Frequency Questionnaire.;Sunlight exposure. Timepoint: At the beginning of the study. Method of measurement: Questionnaire.;Physical activity. Timepoint: At the beginning of the study. Method of measurement: Baecke Physical Activity Questionnaire.